180 related articles for article (PubMed ID: 10409495)
1. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice.
Goumans MJ; Zwijsen A; van Rooijen MA; Huylebroeck D; Roelen BA; Mummery CL
Development; 1999 Aug; 126(16):3473-83. PubMed ID: 10409495
[TBL] [Abstract][Full Text] [Related]
2. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
[TBL] [Abstract][Full Text] [Related]
3. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants.
Palis J; McGrath KE; Kingsley PD
Blood; 1995 Jul; 86(1):156-63. PubMed ID: 7795222
[TBL] [Abstract][Full Text] [Related]
4. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice.
Dickson MC; Martin JS; Cousins FM; Kulkarni AB; Karlsson S; Akhurst RJ
Development; 1995 Jun; 121(6):1845-54. PubMed ID: 7600998
[TBL] [Abstract][Full Text] [Related]
5. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.
Carvalho RL; Itoh F; Goumans MJ; Lebrin F; Kato M; Takahashi S; Ema M; Itoh S; van Rooijen M; Bertolino P; Ten Dijke P; Mummery CL
J Cell Sci; 2007 Dec; 120(Pt 24):4269-77. PubMed ID: 18029401
[TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm.
Bielinska M; Narita N; Heikinheimo M; Porter SB; Wilson DB
Blood; 1996 Nov; 88(10):3720-30. PubMed ID: 8916936
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of the transforming growth factor beta type II receptor disrupts mesoderm organisation during mouse gastrulation.
Zwijsen A; Goumans MJ; Lawson KA; Van Rooijen MA; Mummery CL
Dev Dyn; 1999 Feb; 214(2):141-51. PubMed ID: 10030593
[TBL] [Abstract][Full Text] [Related]
8. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.
Larsson J; Goumans MJ; Sjöstrand LJ; van Rooijen MA; Ward D; Levéen P; Xu X; ten Dijke P; Mummery CL; Karlsson S
EMBO J; 2001 Apr; 20(7):1663-73. PubMed ID: 11285230
[TBL] [Abstract][Full Text] [Related]
9. The mouse KRAB zinc-finger protein CHATO is required in embryonic-derived tissues to control yolk sac and placenta morphogenesis.
Shibata M; García-García MJ
Dev Biol; 2011 Jan; 349(2):331-41. PubMed ID: 21094155
[TBL] [Abstract][Full Text] [Related]
10. TGFbeta inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development.
Poon E; Clermont F; Firpo MT; Akhurst RJ
J Cell Sci; 2006 Feb; 119(Pt 4):759-68. PubMed ID: 16449320
[TBL] [Abstract][Full Text] [Related]
11. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
12. Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation.
Itoh F; Itoh S; Carvalho RL; Adachi T; Ema M; Goumans MJ; Larsson J; Karlsson S; Takahashi S; Mummery CL; Dijke PT; Kato M
Lab Invest; 2009 Jul; 89(7):800-10. PubMed ID: 19398960
[TBL] [Abstract][Full Text] [Related]
13. Analysis of homozygous TGF beta 1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis.
Martin JS; Dickson MC; Cousins FM; Kulkarni AB; Karlsson S; Akhurst RJ
Ann N Y Acad Sci; 1995 Mar; 752():300-8. PubMed ID: 7755275
[No Abstract] [Full Text] [Related]
14. Hedgehog is required for murine yolk sac angiogenesis.
Byrd N; Becker S; Maye P; Narasimhaiah R; St-Jacques B; Zhang X; McMahon J; McMahon A; Grabel L
Development; 2002 Jan; 129(2):361-72. PubMed ID: 11807029
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular overexpression of transforming growth factor-beta(1) causes abnormal yolk sac vasculogenesis and early embryonic death.
Agah R; Prasad KS; Linnemann R; Firpo MT; Quertermous T; Dichek DA
Circ Res; 2000 May; 86(10):1024-30. PubMed ID: 10827131
[TBL] [Abstract][Full Text] [Related]
16. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
[TBL] [Abstract][Full Text] [Related]
17. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.
Serra R; Johnson M; Filvaroff EH; LaBorde J; Sheehan DM; Derynck R; Moses HL
J Cell Biol; 1997 Oct; 139(2):541-52. PubMed ID: 9334355
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis.
Oshima M; Oshima H; Taketo MM
Dev Biol; 1996 Oct; 179(1):297-302. PubMed ID: 8873772
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
